IMMUNE PHARMACEUTICALS INC's ticker is IMNP and the CUSIP is 45254C101. A total of 12 filers reported holding IMMUNE PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $0 | -100.0% | 1,000 | -96.4% | 0.00% | – |
| Q4 2016 | $5,000 | – | 27,500 | +1275.0% | 0.00% | – |
| Q3 2016 | $0 | – | 2,000 | +100.0% | 0.00% | – |
| Q2 2016 | $0 | – | 1,000 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2015 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2015 | $1,000 | -50.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2015 | $2,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2015 | $2,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 197,655 | $144,000 | 0.06% |
| Geduld E E | 35,000 | $26,000 | 0.02% |
| Ifrah Financial Services, Inc. | 15,000 | $11,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 33,837 | $25,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 99,919 | $73,000 | 0.00% |
| Pine River Capital Management L.P. | 250,000 | $4,000 | 0.00% |
| BlackRock Investment Management, LLC | 3,245 | $2,000 | 0.00% |
| LPL Financial LLC | 40,000 | $32,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 58 | $0 | 0.00% |
| MORGAN STANLEY | 52 | $0 | 0.00% |